| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Barth Jay is a Chief Medical Officer at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2019 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 50,000 | $14.20 | $710,195.00 | -27.8% | |
| Feb 25, 2019 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 70,000 | $12.52 | $876,134.00 | -21.2% | |
| May 14, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $14.04 | $70,222.50 | -5.5% | |
| Apr 12, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $14.72 | $73,602.00 | -5.5% | |
| Mar 12, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $15.05 | $75,252.50 | -5.5% | |
| Jan 23, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 20,000 | $16.80 | $336,000.00 | -19.0% | |
| Jan 2, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $14.71 | $73,559.00 | -7.2% | |
| Dec 1, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $13.59 | $67,937.00 | -7.2% | |
| Oct 12, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $14.25 | $71,268.00 | -7.2% | |
| Jun 19, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 30,000 | $10.00 | $300,000.00 | -31.9% |